Alexion, AstraZeneca Rare Disease, is a global pharmaceutical company dedicated to improving health equity for individuals living with rare diseases. Through innovative research, development, and corporate social responsibility initiatives, they strive to provide life-changing medicines and support services for patients and families facing rare and devastating conditions.
Driven by real stories and inspired by individuals like Albie, Ruthie, and Donnan, Alexion, AstraZeneca Rare Disease, is committed to making a meaningful impact in the rare disease community. With a focus on transforming the lives of those affected by rare diseases, they work tirelessly to push the boundaries of medicine and healthcare services to create a better reality for patients worldwide.
Generated from the website